II. Epidemiology
- Incidence: 36% in U.S.
- Most take OTC Medications and do not seek medical help
- GERD patients wait 1-3 years before seeing a doctor
III. Risk Factors: Reduced Lower Esophageal Sphincter (LES) pressure
- Smooth Muscle relaxants
- Tobacco Abuse
- Pregnancy
- Progesterone-mediated relaxation of the lower esophageal sphincter
- Scleroderma
-
Diabetes Mellitus (esp. longer standing disease)
- Esophageal Dysmotility, decreased lower esophageal sphincter tone, prolonged transit time
IV. Complications
- Barrett's Esophagus (10-20% Incidence)
- Asthma
- Persistent Chest Pain
- Chronic Cough
- Dental Erosions (dental enamel loss)
- Hoarseness
- Laryngeal Cancer
- Persistent Pharyngitis
- Vocal Cord Polyps
- Subglottic Stenosis
- Interstitial fibrosis
V. Symptoms: Classic
- Heartburn (Initial GERD symptom)
- Location: Epigastric and retrosternal Chest Pain
- Characteristic: Caustic or stinging
- No radiation to the back
- Acid Regurgitation (Water Brash or Pyrosis)
- Suggests progressing GERD
- Provoked by lying supine or leaning forward
- Regurgitation of digested food or clear burning fluid
- Undigested food suggests alternative diagnosis
- Achalasia
- Esophageal Diverticulum
-
Difficult Swallowing (Dysphagia)
- See Dysphagia from Esophageal Cause
- Mechanical obstruction of solid foods
- Suggests peptic stricture
- Liquid obstruction suggests alternative diagnosis
- Neuromuscular disorder
- Neoplasm
- Esophageal Diverticulum
VI. Symptoms: Atypical
- Abdominal Pain (29%)
-
Chronic Cough (27%)
- GERD is responsible for a non-smoker with 3 weeks of Chronic Cough in 40% of cases
- Consider empiric Proton Pump Inhibitor
- Palombini (1999) Chest 116(2): 279-84 [PubMed]
- Hoarseness (21%)
- Belching (15%)
- Bloating (15%)
- Aspiration (14%)
- Wheezing (7%)
- Globus Hystericus (4%)
- Recurrent Pharyngitis
- Halitosis
VII. Signs: Orofacial effects of chronic Acid Reflux
- Dental Erosions (yellow discoloration)
- Masticatory Mucosa inflammation
- Chronic Sinusitis
VIII. Red Flags: Symptoms Indicating Evaluation (e.g. Endoscopy)
-
Dysphagia
- Immediately assess for Barrett's Esophagus
- Odynophagia
- Assess for Esophageal Ulcer
- Weight Loss (Suggests Dysphagia or Odynophagia)
- Early satiety or Vomiting
- Aspiration
- Wheezing or cough
- Gastrointestinal Bleeding
- Unexplained Iron Deficiency Anemia
- Suggests esophageal ulcer
- High risk patients
- Males age >=50 years old with longstanding GERD symptoms (>=5 years)
- History of severe Erosive Gastritis
- Tobacco Abuse with weekly GERD symptoms in the last year (OR 51.4)
- Obesity (BMI >30 kg/m^2) with weekly GERD symptoms in the last year (OR 34.4)
- Elderly with reflux (use high level of suspicion)
- Even serious pathology may present as mild GERD
- Johnson (2004) Gastroenterology 126:660-4 [PubMed]
IX. Differential Diagnosis
X. Pathophysiology
- Transient relaxation of lower esophageal sphincter
XI. Diagnosis: Typical cases
- See GerdQ Questionnaire
- Symptoms and signs are sufficient for diagnosis for uncomplicated cases
- Empiric management is the recommended strategy for uncomplicated cases
XII. Diagnosis: Complicated or refractory cases
- Upper endoscopy
- Indicated for red flag symptoms (see above)
- Test Sensitivity and Specificity are low for GERD diagnosis
- Standard for evaluating GERD complications (e.g. Barrett Esophagus)
- pH probe (24 hour pH monitoring)
- Indicated prior to Anti-Reflux Surgery (Nissen Fundoplication)
- Test Sensitivity: 70 to 96%
- Test Specificity: 70 to 96%
XIII. Management: General Measures
- Drink 8 glasses (8 ounces) non-caffeinated fluid daily
- Decrease provocative foods
- Tobacco Cessation
- No eating food 2-3 hours before bedtime
- Elevate head of bed to 30 degrees
- Place 6-8 inch blocks under legs at head of bed
- Place Styrofoam wedge under mattress
- Symptomatic therapy for mild intermittent symptoms
XIV. Management: Medications
- Institute general measures above
-
Proton Pump Inhibitor (PPI)
- Onset to full activity requires 7 days (consider concurrent H2 Blocker for first week)
- All Proton Pump Inhibitors equivalent in GERD
- Initial treatment for 6 to 12 weeks
- Dose 30-60 minutes prior to meal
- Use high dose (twice daily or double dose daily) for severe or refractory symptoms
- Taper to lower dose for 4 to 8 weeks
- Trial off Proton Pump Inhibitor after 8-12 weeks
- Limit to 8 weeks in treatment naive patients with classic GERD and no alarm symptoms
- Exception: Continue PPI (lowest effective dose) longterm if Barrett's Esophagus or severe erosive Esophagitis
- Longterm Proton Pump Inhibitors are associated with adverse effects (Clostridium difficile, Osteoporosis)
- Use H2 Blocker for acid rebound symptoms on tapering and stopping PPI
- Consider H2 Blocker maintenance therapy
- Consider concurrent with first week of Proton Pump Inhibitor use (until complete pump blockade)
- Use prn for breakthrough symptoms (esp. after tapering or discontinuing PPI)
- H2 Blockers are inferior to PPI for control of GERD symptoms
- Starting with Proton Pump Inhibitor (instead of stepping up from H2 Blocker) is more cost effective
- Sigterman (2013) Cochrane Database Syst Rev 5:CD002095 [PubMed]
- Habu (2005) J Gastroenterol 40(11): 1029-35 [PubMed]
- Medications not found to be beneficial
- Sucralfate (Carafate) offers minimal benefit in GERD
XV. Management: Refractory (persists despite Proton Pump Inhibitor or recurs when stopped)
- See Red Flags as above
- Restart Proton Pump Inhibitor (e.g. Omeprazole)
- Consider Endoscopy (EGD)
- Evaluate for Barrett's Esophagus
- Consider evaluation for Anti-Reflux Surgery (Nissen Fundoplication)
- Upper Endoscopy (evaluate for Barrett's Esophagus)
- Upper Gastrointestinal Series (defines anatomy)
- Manometry
- 24-Hour pH Monitoring
- Consider other Esophageal Dysmotility
XVI. Management: Follow-up
- Normal upper endoscopy (EGD)
- No repeat EGD for 10 years unless symptoms progress
- Schnell (2001) Gastroenterology 120:1607-19 [PubMed]
XVII. References
- (2022) Presc Lett 29(2): 9-10
- Feldman (1998) Sleisenger GI, Saunders, p. 509-17
- Townsend (2001) Sabiston Surgery, Saunders, p. 755-66
- Anderson (2015) Am Fam Physician 91(10): 692-7 [PubMed]
- Devault (1999) Am J Gastroenterol 94:1434-42 [PubMed]
- Heidelbaugh (2003) Am Fam Physician 68:1311-22 [PubMed]
- Heidelbaugh (2008) Am Fam Physician 78(4): 483-8 [PubMed]
- Horgan (1997) Surg Clin North Am 77(5):1063-82 [PubMed]
- Peters (1998) Ann Surg 228(1):40-50 [PubMed]